• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clinical and Laboratory Diagnosis of Monkeypox (Mpox): Current Status and Future Directions - Cell. Preproof

Mary Wilson

Well-known member
Published: April 26, 2023

DOI: https://doi.org/10.1016/j.isci.2023.106759

Summary

The emergence and rapid spread outside of monkeypox virus (MPXV) to non-endemic countries has brought this once obscure pathogen to the forefront of global public health. Given the range of conditions that cause skin lesions, and because clinical manifestation may more often be atypical in the current mpox outbreak, it can be challenging to diagnose patients based on clinical signs and symptoms, especially for individuals with an atypical clinical presentation. With this perspective in mind, the laboratory-based diagnosis assumes a critical role for the clinical management and the implementation of countermeasures. Here we review the clinical features reported in mpox patients and currently available laboratory tests that are used for mpox diagnosis, discussing their principles, advances, advantages, and drawbacks. We also highlight the diagnostic platforms with the potential of application that guide the field’s ongoing and future work, particularly to increase diagnostic capacity in low- and middle-income countries. With the outlook of this evolving research area, we hope to inspire more research and development of diagnostic alternatives to better prepare our society for dealing with future public health crises.

https://www.cell.com/action/showPdf?pii=S2589-0042(23)00836-2
 
Back
Top